Empyema and parapneumonic pleural effusion. Prognostic factors about 109 patients

M. Gosset-Woimant, C. Andrejak, C. Poulet, D. Basille, H. Bentayeb, M. Boutemy, E. Lecuyer, S. Thielen, N. Benoit, J. Montconduit, F. Martin, O. Leleu, C. Clarot, V. Jounieaux, C. Dayen, Y. Douadi (Amiens, Saint Quentin, Compiègne, Abbeville, France)

Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Session: Assessment of severity in respiratory infections: severity scales and biomarkers
Session type: Thematic Poster Session
Number: 2379
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Gosset-Woimant, C. Andrejak, C. Poulet, D. Basille, H. Bentayeb, M. Boutemy, E. Lecuyer, S. Thielen, N. Benoit, J. Montconduit, F. Martin, O. Leleu, C. Clarot, V. Jounieaux, C. Dayen, Y. Douadi (Amiens, Saint Quentin, Compiègne, Abbeville, France). Empyema and parapneumonic pleural effusion. Prognostic factors about 109 patients. Eur Respir J 2009; 34: Suppl. 53, 2379

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of outcome in parapneumonic pleural effusions in children
Source: Eur Respir J 2001; 18: Suppl. 33, 171s
Year: 2001

Prognostic features of residual pleural thickening after parapneumonic pleural effusion
Source: Eur Respir J 2002; 20: Suppl. 38, 605s
Year: 2002

Prognostic features of residual pleural thickening in parapneumonic pleural effusions
Source: Eur Respir J 2003; 21: 952-955
Year: 2003



Predictive factors, microbiology and outcome of patients with parapneumonic effusion
Source: Eur Respir J 2011; 38: 1173-1179
Year: 2011



Management of parapneumonic effusion and empyema in children
Source: Eur Respir J 2002; 20: Suppl. 38, 589s
Year: 2002

Evaluation of patients with pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 247s
Year: 2004

Update on the management of parapneumonic pleural effusions
Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021
Year: 2021


Risk factors for parapneumonic effusion in community-asquired pneumonia
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019


Treatment results of patients with complicated parapneumonic effusion and empyema
Source: Eur Respir J 2002; 20: Suppl. 38, 358s
Year: 2002

Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion
Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status
Year: 2021


Parapneumonic pleural effusion as a cause of hypoalbumunemia in pediatric patients
Source: Eur Respir J 2006; 28: Suppl. 50, 309s
Year: 2006

Parapneumonic effusion and empyema
Source: Respipedia Article
Year: 2017

Treatment of parapneumonic pleural effusion and empyema: conservative view
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=199
Year: 2004

Procalcitonin in pleural fluid: A new tool for the diagnosis of empyema and parapneumonic pleural effusions?
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011

Prognostic factors in patients with malignant pleural effusion undergoing thoracoscopy
Source: Annual Congress 2011 - From outside to inside: access to the pleura
Year: 2011

Lung function in children post parapneumonic effusion and empyema
Source: Eur Respir J 2002; 20: Suppl. 38, 590s
Year: 2002

Medical pleuroscoy, role in undiagnosed pleural effusion and therapy for pneumothorax and recurrent pleural effusion
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013